Business Wire

Neurescue's Breakthrough Intelligent Balloon Catheter FDA 510(k) Cleared for Hemorrhage Control and IDE Approved for Cardiac Arrest

COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a medical device company developing innovative cardiovascular solutions to improve the outcomes for emergency patients, today announced that the U.S.
Business Wire

Neurescue Announces Appointment of Medtronic Veteran Mette-Marie Harild to Company’s Board of Directors

COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a clinical-stage medical device company bringing to market the world’s first computer-aided balloon catheter for aortic occlusion, today announced that ...
BioWorld

Neurescue’s aortic occlusion device gets FDA nod for hemorrhage and IDE for cardiac arrest

The FDA granted Neurescue a "two-fer" on its intelligent balloon catheter for aortic occlusion with 510(k) clearance for emergency control of hemorrhage and investigational device exemption for use in ...
Enid News & Eagle

NEURESCUE Device Secures Historic CE Mark Approval for Non‑Shockable Cardiac Arrest Treatment

Neurescue ApS today announced CE Mark approval for the NEURESCUE ® device, the first and only medical device approved to treat non-shockable cardiac arrest. Granted by TÜV SÜD after an expedited ...